Zynex, Inc. (ZYXI)

Market Cap	228.97M
Revenue (ttm)	193.67M
Net Income (ttm)	4.82M
Shares Out	31.85M
EPS (ttm)	0.15
PE Ratio	48.68
Forward PE	19.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220,757
Open	7.41
Previous Close	7.41
Day's Range	7.12 - 7.50
52-Week Range	7.12 - 13.77
Beta	0.55
Analysts	Strong Buy
Price Target	14.00 (+94.72%)
Earnings Date	Mar 7, 2025

About ZYXI

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,100
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYXI
• Website: https://www.zynex.com

Financial Performance

In 2023, Zynex's revenue was $184.32 million, an increase of 16.54% compared to the previous year's $158.17 million. Earnings were $9.73 million, a decrease of -42.91%.

Analyst Forecast

According to 2 analysts, the average rating for ZYXI stock is "Strong Buy." The 12-month stock price forecast is $14.0, which is an increase of 94.72% from the latest price.

Price Target

$14.0

(94.72% upside)

Analyst Consensus: Strong Buy